Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Performance of a Highly-sensitive Rapid Diagnostic Test (RDT) Versus Conventional RDT, Compared With PCR as the Gold Standard, in Reactive Case Detection of Malaria Infections in Rakhine State, Myanmar

NCT03511443 is registered in ClinicalTrials.gov with University Research Co, LLC as lead sponsor.

NCT NCT03511443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03511443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Performance of a Highly-sensitive Rapid Diagnostic Test (RDT) Versus Conventional RDT, Compared With PCR as the Gold Standard, in Reactive Case Detection of Malaria Infections in Rakhine State, Myanmar
Lead sponsor
University Research Co, LLC
Phase
Not applicable
Overall status
Unknown status
Start date
October 2, 2017
Completion date
October 1, 2018
Enrollment
1,980 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria diagnosis, malaria,falciparum